If the election results were based on how many people attend a candidate's events, Kamala Harris would be the Democratic frontrunner.
Gravy Analytics, a location-based marketing technology company, analyzed the smartphone data of people who attended the 111 solo Democratic presidential candidate events held in June and July. (Gravy disqualified other official party events as well as rallies held for multiple candidates.)
The company analyzed data it received from 100,000 apps it partners with. Users opt in to the tracking via permissions given to the app and the company says it accounts for users who may be logged in to several of the apps at once. The results, which are anonymized and grouped for statistical purposes, were shared first with Cheddar.
"Whether it's a Democratic presidential candidate, whether it's a movie, or whether it's a new wine launching in Sonoma, we just believe a true interest level is gauged by people's time and commitment to attend things like events rather than interest online," said Gravy Analytics CEO Jeff White.
"It shows much more interest if someone goes to Joe Biden's speaking event versus reading an article online about him," he added.
Presidential campaign rallies have been an unofficial bellwether for popularity. President Barack Obama's events cemented his strong support among youth, while President Donald Trump's attendance showed his passionate following better than most polls predicted.
In terms of total attendance, Gravy Analytics found most people went to Harris' events, followed by Cory Booker, Elizabeth Warren, Bernie Sanders, and Julián Castro. More than a quarter of the people who attended these events were between the ages of 18 to 34, and 56 percent were men. More than nine out of 10 people only went to one event.
Other interesting insights include:
As the US braces for the what's the follow after the end of the Title 43 pandemic-related restrictions, experts discuss the ramifications with Cheddar News.
A man who kept a chokehold around the neck of an agitated fellow passenger in the New York City subway has turned himself in on a manslaughter charge.
New York State Senator John Liu spoke with Cheddar News about Asian-American representation in politics, his bill to make Asian-American history mandatory in schools, and the ongoing hate crimes against his community. State Sen. Liu also discussed the debate over student loan forgiveness and gave his take on artificial intelligence in education.
The Senate Banking Committee held a hearing Thursday on the cannabis bill the Secure and Fair Enforcement (SAFE) Banking — a first step toward what advocates hope will be a full vote on the Senate Floor.
New blood donations rules will allow sexually active gay and bisexual men in monogamous relationships to give in the FDA guidelines ease decades-old restrictions put in place to protect the blood supply from HIV.
During a contentious CNN town hall Wednesday night, former President Donald Trump dug in on his lies about the 2020 election, downplayed the violence on Jan. 6, 2021, and repeatedly insulted the woman whom a civil jury this week found him liable of sexually abusing and defaming.
Criminal defense attorney Tamara Holder joined Cheddar News to break down the charges that New York Republican Congressman George Santos is facing. "When the feds come after you -- and this is for anyone, a politician or not -- they generally have already built their case before they indict you," Holder said, regarding the timeline of Rep. Santos' arrest.
Officials in Missouri's largest city are moving to declare it a sanctuary for people seeking or providing gender-affirming care, defying state officials who are intent on banning it for minors and restricting it for adults.
The Biden administration on Thursday will begin denying asylum to migrants who arrive at the U.S.-Mexico border without first applying online or seeking protection in a country they passed through.
Federal health advisers said Wednesday that a decades-old birth control pill should be sold without a prescription, paving the way for a likely U.S. approval of the first over-the-counter contraceptive medication.
